Afuco™ Anti-Human CLEC14A ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CLEC14A ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel antibody specifically binding to the clec14a (C-type lectin domain family 14, member A) and the antibody can effectively inhibit cle14a-mediated cancer progression.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-162CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CLEC14A |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |